Royalty Pharma PLC expected to post earnings of 81  cents a share - Earnings Preview

Royalty Pharma

04/08/2023 19:38

* Royalty Pharma PLC  RPRX.OQ   RPRX.O  is expected to show
a rise
in quarterly revenue when it reports  results on August 8. 
    * The New York City-based  company is expected to report  a
0.1% increase in revenue to $536.593 million from $536 million a
year ago, according to the mean estimate from 3 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Royalty Pharma PLC
is for
earnings of 81 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Royalty
Pharma
PLC is $48.8​, above​ its last closing price of $30.59. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  1.30        1.27       1.60      Beat    25.7
 Dec. 31 2023  1.39        1.47       1.56      Beat    5.9
 Sep. 30 2022  0.71        0.72       0.72      Met     0.5​
 Jun. 30 2022  0.79        0.78       0.79      Beat    1.1
 ​​Mar.        0.74        0.73       0.60      Missed  -18
 31 2022                                                
 Dec. 31 2021  0.77        0.78       0.80      Beat    3.2​
 Sep. 30 2021  0.68        0.69       0.17      Missed  -75.4
 Jun. 30 2021  0.69        0.70       1.08      Beat    55.4
 This summary was machine generated August 4 at 18:38 GMT.  All
figures in US dollars  unless otherwise stated